IntelliCell BioSciences Inc:企業の戦略的SWOT分析

◆英語タイトル:IntelliCell BioSciences Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C12941
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

IntelliCell BioSciences Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

IntelliCell BioSciences Inc (IntelliCell BioSciences) is a regenerative medicine company. The company’s flagship IntelliCell patented technology helps extract, separate and process stromal vascular fraction (SVF) cells from the blood vessels in adult adipose (fat) tissue. SVF cells derived from a body’s fat can be used to treat ailments or rejuvenate diseased or damaged tissue and cell functions. The company also carries out the development of autologous and allogeneic cells from living and non-living tissue donors for research purposes. It identified technologies and laboratory processes to develop products and services in personalized medicine for the regeneration, prevention, and cure of age related disease states. IntelliCell BioSciences is headquartered in New York, the US.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
IntelliCell BioSciences Inc – Key Facts 5
IntelliCell BioSciences Inc – Key Employees 6
IntelliCell BioSciences Inc – Key Employee Biographies 7
IntelliCell BioSciences Inc – Major Products and Services 8
IntelliCell BioSciences Inc – History 9
IntelliCell BioSciences Inc – Company Statement 11
IntelliCell BioSciences Inc – Locations And Subsidiaries 12
Head Office 12
Section 2 – Company Analysis 13
Company Overview 13
IntelliCell BioSciences Inc – Business Description 14
IntelliCell BioSciences Inc – Corporate Strategy 15
IntelliCell BioSciences Inc – SWOT Analysis 16
SWOT Analysis – Overview 16
IntelliCell BioSciences Inc – Strengths 16
IntelliCell BioSciences Inc – Weaknesses 17
IntelliCell BioSciences Inc – Opportunities 18
IntelliCell BioSciences Inc – Threats 19
IntelliCell BioSciences Inc – Key Competitors 20
Section 3 – Company’s Lifesciences Financial Deals and Alliances 21
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 21
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 22
IntelliCell BioSciences Inc, Recent Deals Summary 23
Section 4 – Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
IntelliCell BioSciences Inc, Key Facts 5
IntelliCell BioSciences Inc, Key Employees 6
IntelliCell BioSciences Inc, Key Employee Biographies 7
IntelliCell BioSciences Inc, Major Products and Services 8
IntelliCell BioSciences Inc, History 9
IntelliCell BioSciences Inc, Key Competitors 20
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 21
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 22
IntelliCell BioSciences Inc, Recent Deals Summary 23

List of Figures
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 21
IntelliCell BioSciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 22

★海外企業調査レポート[IntelliCell BioSciences Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • E.ON SE (EOAN):電力:M&Aディール及び事業提携情報
    Summary E.ON SE (E.ON), formerly E.ON AG, is an energy company that generates electricity, produces, stores, transports and supplies gas, and conducts trading, carbon sourcing, and electricity and gas distribution. It generates power from diverse fuel sources including wind, hydro, nuclear, coal, na …
  • Solaria Energia y Medio Ambiente S.A. (SLR):電力:M&Aディール及び事業提携情報
    Summary Solaria Energia y Medio Ambiente, S.A. (Solaria) is a manufacturer and supplier of photovoltaic (PV) modules and cells, and provider of turnkey projects. It designs, manufactures, supplies, and installs PV and thermal solutions for power generation. Its product portfolio includes PV modules …
  • Newalta Corp (NAL):石油・ガス:M&Aディール及び事業提携情報
    Summary Newalta Corp (Newalta) is a provider of sustainability-enhancing solutions to the oil and gas industry. It adopts technologies to maximize the value inherent in oil and gas exploration and production waste streams. The company provides engineered environmental solutions for waste management …
  • Altana Ag:企業の戦略・SWOT・財務分析
    Altana Ag - Strategy, SWOT and Corporate Finance Report Summary Altana Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • LG International Corp (001120):企業の財務・戦略的SWOT分析
    LG International Corp (001120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Kadimastem Ltd (KDST):企業の財務・戦略的SWOT分析
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • Purdue Pharma L.P.:企業のM&A・事業提携・投資動向
    Purdue Pharma L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Purdue Pharma L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Sandvik AB:企業の戦略・SWOT・財務情報
    Sandvik AB - Strategy, SWOT and Corporate Finance Report Summary Sandvik AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Syntel, Inc.:戦略・SWOT・企業財務分析
    Syntel, Inc. - Strategy, SWOT and Corporate Finance Report Summary Syntel, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Village Roadshow Ltd:企業の戦略・SWOT・財務情報
    Village Roadshow Ltd - Strategy, SWOT and Corporate Finance Report Summary Village Roadshow Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Owen Mumford Ltd:企業の戦略的SWOT分析
    Owen Mumford Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Protea Biosciences Group Inc:医療機器:M&Aディール及び事業提携情報
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnostic applica …
  • Egyptian Resorts Co:企業の戦略・SWOT・財務分析
    Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report Summary Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ryanair Holdings plc:企業の戦略・SWOT・財務情報
    Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • NRG Energy Inc (NRG):企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ABN AMRO Group NV (ABN):企業の財務・戦略的SWOT分析
    ABN AMRO Group NV (ABN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Frasers Property Australia Pty Ltd:企業の戦略的SWOT分析
    Frasers Property Australia Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Restalia Grupo de Eurorestauracion SL:企業の戦略・SWOT・財務分析
    Restalia Grupo de Eurorestauracion SL - Strategy, SWOT and Corporate Finance Report Summary Restalia Grupo de Eurorestauracion SL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • B&G Foods, Inc.:企業のM&A・事業提携・投資動向
    B&G Foods, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's B&G Foods, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆